Culture & Team
CureGBM is dedicated to pioneering a breakthrough in brain tumour treatment through innovative sonodynamic therapy. Our non-invasive approach gently targets tumours, improving patient outcomes and enhancing their quality of life. Join us in our mission to transform healthcare.
We put YOU at the centre of all our plans.
We will bring the safest, gentlest and most exciting new treatment method for GBM: Sonodynamic Therapy, to Europe and the wider world.
Richard and Jane lost their father to GBM during 2021, and didn’t manage to spend much time with him in the two months between diagnosis and him passing away.
They worked with cancer neuroscientists, neurosurgeons and biomedical engineers to create CureGBM to help preserve the memory of their cherished father, leaving a
We are grateful to our funders and investors, as their contributions will allow all patients to be enrolled in our trials for FREE, enabling them and their families to concentrate their energy on fighting GBM.
Meet the Team
Richard Wakefield
Founder CureGBM
Richard’s commitment and reason for founding CureGBM is deeply personal. After losing his father to glioblastoma in 2021, Rich made it his mission to push forward meaningful change in the brain cancer space. Despite a busy family life as husband and father of two boys, he remains fully dedicated to making CureGBM a success. His drive is fuelled by love, loss, and a determination to ensure that no family faces GBM alone.
Rich brings a unique blend of discipline, resilience, and entrepreneurial drive to CureGBM. Having served in the British Army, he developed strong leadership and problem-solving skills that continue to shape his approach to building impactful initiatives.
Over the years, he has lived and worked across UK, Germany, Switzerland and Austria, now based in Vienna, successfully growing companies from the ground up into independent enterprises.
Rich leads with heart and purpose—turning personal tragedy into collective hope.
Philippe Schucht
Professor of Neurosurgery
and Trial PI
Prof. Philippe Schucht is a leading neurosurgeon specializing in brain tumor and vascular surgery for both adults and children. As Head of Neuro-Oncology at the University Hospital Bern, he is known for combining surgical excellence with cutting-edge technology to deliver the best possible outcomes for his patients.
With international training under some of the world’s top neurosurgeons, Philippe brings decades of experience and a global perspective to his work. He has led numerous clinical trials, founded medical companies, and continues to pioneer new approaches in brain tumor treatment—always with the goal of improving prognosis and preserving quality of life.
Philippe is deeply committed to education and global health. He co-founded the Swiss Young Neurosurgeons and established a humanitarian NGO that trains medical teams in Myanmar, helping improve care for children and young adults.
Jane Oberholzer
Patient Advocate CureGBM
Jane brings a deeply personal and compassionate perspective to CureGBM as its dedicated Patient Advocate. Having lived and worked in both London and Zurich, she balances a demanding career in asset management with a rich family life and active involvement in community philanthropy.
Her commitment to CureGBM is rooted in her own experience—when her father was diagnosed with glioblastoma (GBM), she faced the journey with minimal support. Today, she channels that experience into being a steady, empathetic presence for patients and families navigating the same path.
Jane ensures that no one feels alone, offering a listening ear, heartfelt guidance, and unwavering advocacy. Her role is not just professional—it’s profoundly personal, and her impact resonates in every life she touches.
Safety protocols & monitoring mandated by the SwissMedic health authority have been observed throughout design and delivery of our trials.
